Puma Biotechnology Share Price Today
(NASDAQ: PBYI)

Name: Puma Biotechnology Share Price Today (NASDAQ: PBYI) - Puma Biotechnology Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Puma Biotechnology share price is $3.54 & ₹307.87 as on 6 Mar 2025, 2.30 'hrs' IST

$3.54

▲

0.15

(4.42%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Puma Biotechnology share price in Dollar and Rupees. Guide to invest in Puma Biotechnology stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Puma Biotechnology, along with analyst recommendations, forecasts, and comprehensive financials.

Puma Biotechnology share price movements

Today's Low: $3.38
Today's High: $3.54
$3.54
4.66%
Downside
Day's Volatility :4.66%
Upside
0.0%
52 Weeks Low: $2.23
52 Weeks High: $6.06
$3.54
37.15%
Downside
52 Weeks Volatility :63.25%
Upside
41.54%

Puma Biotechnology (PBYI) Returns

Period	Puma Biotechnology, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	10.42%	2.1%	0.0%
6 Months	47.39%	-4.1%	0.0%
1 Year	-38.7%	2.2%	0.0%
3 Years	39.51%	11.8%	-11.6%

Puma Biotechnology (PBYI) Key Statistics

in dollars & INR

Previous Close	$3.39
Open	$3.4
Today's High	$3.54
Today's Low	$3.375
Market Capitalization	$168.2M
Today's Volume	$105.6K
52 Week High	$6.055
52 Week Low	$2.225
Revenue TTM	$230.5M
EBITDA	$42.5M
Earnings Per Share (EPS)	$0.63
PE Ratio	5.38
Profit Margin	13.14%
Quarterly Earnings Growth YOY	0.59%
Return On Equity TTM	41.6%

How to invest in Puma Biotechnology Stock (PBYI) from India?

It is very easy for Indian residents to invest directly in Puma Biotechnology from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Puma Biotechnology stock in both Indian Rupees (INR) and US Dollars (USD). Search for Puma Biotechnology or PBYI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Puma Biotechnology or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Puma Biotechnology shares which would translate to 0.246 fractional shares of Puma Biotechnology as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Puma Biotechnology, in just a few clicks!

Returns in Puma Biotechnology (PBYI) for Indian investors in Rupees

The Puma Biotechnology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Puma Biotechnology investment value today

Current value as on today

₹68,977

Returns

₹31,023

(-31.02%)

Returns from Puma Biotechnology Stock

₹35,986 (-35.99%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Puma Biotechnology (PBYI)

-44%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Puma Biotechnology Stock from India on INDmoney has decreased by -44% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Puma Biotechnology

BlackRock Inc
7.79%
Vanguard Group Inc
7.42%
Millennium Management LLC
3.86%
Renaissance Technologies Corp
3.58%
Athyrium Capital Management LP
2.56%
Eversept Partners, LLC
2.03%

Analyst Recommendation on Puma Biotechnology

Sell

12%Buy

37%Hold

50%Sell

Based on 8 Wall street analysts offering stock ratings for Puma Biotechnology(by analysts ranked 0 to 5 stars)

Based on 8 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Puma Biotechnology Stock (PBYI)

What analysts predicted

Upside of 22.41%

Target:

$4.33

Current:

$3.54

Insights on Puma Biotechnology Stock (Ticker Symbol: PBYI)

Price Movement
In the last 7 days, PBYI stock has moved up by 22.4%
Decreasing Revenue
Revenue is down for the last 2 quarters, 80.54M → 59.07M (in $), with an average decrease of 26.7% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, 20.31M → 19.30M (in $), with an average decrease of 5.0% per quarter
PBYI vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 96.9%
PBYI vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 13.2%
Price to Sales
ForPBYI every $1 of sales, investors are willing to pay $0.7, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Puma Biotechnology Technicals Summary

Sell

Neutral

Buy

Puma Biotechnology is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Puma Biotechnology (PBYI) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Puma Biotechnology, Inc.	20.21%	47.39%	-38.7%	39.51%	-64.35%
Regeneron Pharmaceuticals, Inc.	1.3%	-41.29%	-30.51%	9.2%	42.38%
Beone Medicines Ltd	15.19%	34.31%	61.3%	43.16%	68.1%
Vertex Pharmaceuticals Incorporated	3.37%	3.77%	18.06%	106.43%	121.36%
Alnylam Pharmaceuticals, Inc.	-11.52%	-3.4%	62.32%	49.04%	120.93%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Puma Biotechnology, Inc.	5.38	5.38	0.03	0.54	0.42	0.09	NA	1.88
Regeneron Pharmaceuticals, Inc.	17.85	17.85	1.03	43.09	0.16	0.07	0.01	273.57
Beone Medicines Ltd	NA	NA	NA	1.43	-0.19	-0.06	NA	31.22
Vertex Pharmaceuticals Incorporated	32.84	NA	1.33	18.07	-0.03	0.13	NA	63.87
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	0.57	-15.01	-0.03	NA	0.52

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Puma Biotechnology, Inc.	Sell	$168.2M	-64.35%	5.38	13.14%
Regeneron Pharmaceuticals, Inc.	Buy	$74.9B	42.38%	17.85	31.07%
Beone Medicines Ltd	NA	$28.5B	68.1%	NA	-16.92%
Vertex Pharmaceuticals Incorporated	Buy	$124.1B	121.36%	32.84	-4.86%
Alnylam Pharmaceuticals, Inc.	Buy	$31.5B	120.93%	NA	-12.37%

About Puma Biotechnology

Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage HER2-overexpressed/amplified breast cancer; and advanced or metastatic HER2-positive breast cancer when combined with capecitabine. It also develops alisertib, a small molecule inhibitor of aurora kinase A for the treatment of hormone receptor positive breast cancer, triple negative breast cancer, small cell lung cancer, and head and neck cancer. The company sells its products through specialty pharmacy and distributor networks. It has license agreements with Pfizer Inc. for the development, manufacture, and commercialization of neratinib (oral), neratinib (intravenous), PB357, and related compounds; and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of alisertib, as well as sub-license agreements with Specialised Therapeutics Asia Pte Ltd., Medison Pharma Ltd., Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.

Organization	Puma Biotechnology
Employees	0
CEO	Mr. Alan H. Auerbach
Industry	Health Technology

Management People of Puma Biotechnology

Name	Title
Mr. Alan H. Auerbach	Founder, Chairman, President, CEO & Secretary
Mr. Maximo F. Nougues	CFO & Principal Accounting Officer
Mr. Douglas Hunt B.Sc., FRAPS	Chief Regulatory Affairs, Medical Affairs, Pharmacovigilance & Law Officer
Mr. Jeffrey Jerome Ludwig	Chief Commercial Officer
Mr. Mariann Ohanesian	Senior Director of Investor Relations

Important FAQs about investing in PBYI Stock from India :

What is Puma Biotechnology share price today?

Puma Biotechnology share price today stands at $3.54, Open: $3.40 ; Previous Close: $3.39 ; High: $3.54 ; Low: $3.38 ; 52 Week High: $6.06 ; 52 Week Low: $2.23.

The stock opens at $3.40, after a previous close of $3.39. The stock reached a daily high of $3.54 and a low of $3.38, with a 52-week high of $6.06 and a 52-week low of $2.23.

Can Indians buy Puma Biotechnology shares?

Yes, Indians can invest in the Puma Biotechnology (PBYI) from India.

With INDmoney, you can buy Puma Biotechnology at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Puma Biotechnology at zero transaction cost.

How can I buy Puma Biotechnology shares from India?

It is very easy to buy Puma Biotechnology from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Puma Biotechnology (PBYI) be purchased?

Yes, you can buy fractional shares of Puma Biotechnology with INDmoney app.

What are the documents required to start investing in Puma Biotechnology stocks?

To start investing in Puma Biotechnology, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.